Oct 2
Filing
SEDAR+
Notice
NAV · NAVCO Pharmaceuticals Inc.
Market Cap
285,347 CAD
Shares
57.07M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Investor day
Close0.0050 CAD
Open0.0050 CAD
Day0.0050–0.0050 CAD
52W close0.0050–0.0100 CAD
Avg vol 30d15K
DataJan 2020–Oct 2026
Latest documents
2026
Oct 2
Filing
SEDAR+
Letter from successor auditor
Oct 2
Filing
SEDAR+
Letter from former auditor
Aug 27
Filing
SEDAR+
52-109FV2 - Certification of interim filings - CFO (E)
Aug 27
Filing
SEDAR+
52-109FV2 - Certification of interim filings - CEO (E)
Technicals
trend & momentum for long-term holders illustrative — not investment advicePrice context
position in its 52-week range
Range low 0.0050 CAD
Now 0.0050 CAD · 0%
Range high 0.0100 CAD
vs 200-day avg -64%
vs 50-day avg -21%
Illustrative technical + ownership context — a signal mix, not investment advice.
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XTSX:NAV | +0.0% | +0.0% | -50.0% | +0.0% | -50.0% |
Exchange listing
- Market
- XTSX
- Ticker
- NAV
- ISIN
- —
- Security
- Ordinary share
- Trading currency
- CAD
Company
No verified company website is available for this listing yet.
Other listings of this company
No other verified listings are available.
Latest price
Plus & ProFollow NAV during the session: the latest price, the day's change, range and volume. Closing prices stay free.
Recent dividends
No verified dividend payments are available for this listing yet.
Upcoming investor events
No upcoming investor events are listed for this company yet.
Earnings calls
No earnings calls have been captured for this company yet.